Miller Steve
Insider CIK 1402535 · CPRX Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 47,826 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 16,534 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,873 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 158,454 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 202,958 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 248,004 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 146,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 185,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 275,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 180,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 1,093,803 | $31.50 | $34.45M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 14,000 | — | $0 | 1,471,649 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 14,000 | — | $0 | 1,093,803 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 11,873 | — | $0 | 1,485,649 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 11,873 | — | $0 | 1,079,803 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 8,267 | — | $0 | 1,497,522 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 8,267 | — | $0 | 1,067,930 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 47,826 | — | $0 | 1,489,255 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 158,454 | — | $0 | 1,457,963 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-08-27 | 2025-08-28 | 110,000 | — | $0 | 1,299,509 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-08-27 | 2025-08-28 | 110,000 | $2.24 | $246.4K | 1,059,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-08-26 | 2025-08-28 | 115,000 | — | $0 | 1,409,509 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-08-26 | 2025-08-28 | 115,000 | $20.28 | $2.33M | 949,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-08-26 | 2025-08-28 | 115,000 | $2.24 | $257.6K | 1,064,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 13,667 | — | $0 | 1,524,509 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 13,667 | — | $0 | 949,663 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 14,000 | — | $0 | 1,538,176 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 14,000 | — | $0 | 935,996 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-13 | 2024-12-17 | 235,000 | — | $0 | 1,552,176 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-13 | 2024-12-17 | 235,000 | $4.01 | $942.4K | 921,996 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-10 | 2024-12-11 | 50,000 | — | $0 | 1,787,176 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-12-10 | 2024-12-11 | 50,000 | $21.93 | $1.10M | 686,996 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-10 | 2024-12-11 | 50,000 | $4.01 | $200.5K | 736,996 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 11,872 | — | $0 | 1,837,176 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 11,872 | — | $0 | 686,996 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 24,801 | — | $0 | 1,849,048 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 202,958 | — | $0 | 1,824,247 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-20 | 2024-08-22 | 50,000 | $20.21 | $1.01M | 725,124 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-20 | 2024-08-22 | 50,000 | $20.26 | $1.01M | 775,124 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-20 | 2024-08-22 | 50,000 | $20.59 | $1.03M | 675,124 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 13,667 | — | $0 | 1,621,289 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 13,667 | — | $0 | 825,124 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 14,000 | — | $0 | 1,634,956 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 14,000 | — | $0 | 811,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-11 | 2023-12-13 | 150,000 | — | $0 | 1,648,956 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-11 | 2023-12-13 | 150,000 | $1.13 | $169.5K | 797,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 35,618 | — | $0 | 1,798,956 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 248,004 | — | $0 | 1,763,338 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-05 | 2023-12-07 | 40,000 | $14.24 | $569.6K | 647,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-05-11 | 2023-05-12 | 100,000 | — | $0 | 1,515,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-05-11 | 2023-05-12 | 100,000 | $0.79 | $79.0K | 687,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 13,666 | — | $0 | 1,615,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 13,666 | — | $0 | 587,457 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 42,000 | — | $0 | 1,629,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 146,000 | — | $0 | 1,587,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 20,000 | — | $0 | 1,441,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 20,000 | — | $0 | 573,791 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-23 | 20,000 | $17.34 | $346.8K | 553,791 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-21 | 2022-11-23 | 80,000 | $15.28 | $1.22M | 573,791 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-13 | 2022-09-15 | 7,933 | $17.11 | $135.7K | 728,791 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-13 | 2022-09-15 | 25,000 | $17.01 | $425.3K | 736,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-09-13 | 2022-09-15 | 75,000 | $16.85 | $1.26M | 653,791 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-08-18 | 2022-08-19 | 118,575 | — | $0 | 1,492,425 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-08-18 | 2022-08-19 | 31,425 | — | $0 | 1,461,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 118,575 | $13.56 | $1.61M | 761,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 118,575 | $2.53 | $300.0K | 880,299 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-18 | 2022-08-19 | 31,425 | $13.43 | $422.0K | 761,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 31,425 | $2.53 | $79.5K | 793,149 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 41,000 | — | $0 | 1,611,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 185,000 | — | $0 | 1,570,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 20,000 | — | $0 | 1,385,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 20,000 | — | $0 | 761,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-08-25 | 2021-08-26 | 120,000 | — | $0 | 1,405,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-25 | 2021-08-26 | 120,000 | $3.12 | $374.4K | 821,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-25 | 2021-08-26 | 80,000 | $5.56 | $444.8K | 741,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-08-13 | 2021-08-17 | 65,000 | — | $0 | 1,525,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-13 | 2021-08-17 | 65,000 | $3.12 | $202.8K | 742,687 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-13 | 2021-08-17 | 40,963 | $6.09 | $249.5K | 701,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 275,000 | — | $0 | 1,590,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-22 | 2020-12-28 | 20,000 | — | $0 | 1,315,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-28 | 20,000 | — | $0 | 677,687 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 180,000 | — | $0 | 1,275,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 60,000 | — | $0 | 1,335,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 945,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 1,020,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 75,000 | — | $0 | 1,095,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 775,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 680,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 95,000 | — | $0 | 870,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-06 | 2017-11-07 | 200,000 | — | $0 | 285,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-06 | 2017-11-07 | 200,000 | $0.47 | $94.0K | 657,687 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 785,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 735,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 50,000 | — | $0 | 685,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 725,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 50,000 | — | $0 | 675,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-01-11 | 2016-01-12 | 7,933 | $1.80 | $14.3K | 457,687 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 625,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 575,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 50,000 | — | $0 | 525,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-08-25 | 2015-08-27 | 60,000 | — | $0 | 475,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-08-25 | 2015-08-27 | 60,000 | $1.09 | $65.4K | 449,754 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2014-10-02 | 2014-10-03 | 175,000 | — | $0 | 535,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2014-10-02 | 2014-10-03 | 175,000 | $0.90 | $157.5K | 389,754 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 61,667 | — | $0 | 710,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 61,667 | — | $0 | 648,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 61,666 | — | $0 | 586,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-06-04 | 2014-06-04 | 100,000 | $2.17 | $217.0K | 214,754 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 473,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,666 | — | $0 | 406,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 66,667 | — | $0 | 540,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-03 | 2012-07-05 | 27,700 | $0.55 | $15.2K | 114,754 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-07-03 | 2012-07-05 | 12,300 | $0.55 | $6.8K | 87,054 | SEC↗ |